MedTrace Logo

The Effects of Whey vs. Collagen on MPS

NCT03281434 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2020-02-10

No results posted yet for this study

Summary

With aging there is a natural loss of muscle mass and strength called sarcopenia, which increases the risk of falls and metabolic disease (i.e. Type II diabetes) and decreases the ability to perform activities of daily living. Eating protein and doing resistance exercise both increase the body's ability to make muscle protein, which is important to offset losses in muscle mass; however, older adults have a lower appetite and do not consume enough calories or protein to crease muscle and as such investigations in this population are needed. The amino acid (the building blocks of proteins) leucine is known to increase the ability of protein to make muscle. In this study we will investigate the ability of beverages with different types of protein and leucine to create muscle in older men and women whoa re particularly vulnerable to muscle losses and do not eat enough protein and are understudied in this area.

Conditions

  • Aging

Interventions

DIETARY_SUPPLEMENT

Collagen peptide

Low leucine content protein supplement to be consumed twice daily

DIETARY_SUPPLEMENT

Whey protein isolate

High quality protein (DIAAS score), high leucine supplement, to be consumed twice daily

Sponsors & Collaborators

Principal Investigators

  • Stuart M Phillips, Ph.D. · McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-08-30
Completion
2019-08-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03281434 on ClinicalTrials.gov